Selected Grants
Characterization of a Novel E. coli Type III Secretion System Associated with Increased Patient Mortality
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2027OPTIMIZE
ResearchPrincipal Investigator · Awarded by DCRI-Duke-Site · 2023 - 2026Identification of novel pathogen-specific drug targets in gram-negative bacteria (JCVI CDC U54 - Medium Collaborative)
ResearchPrincipal Investigator · Awarded by J. Craig Venter Institute · 2021 - 2025Optimizing the Outcomes of Adults with Gram-Negative Bloodstream Infections
Clinical TrialPrincipal Investigator · Awarded by Johns Hopkins University · 2023 - 2025Duke CTSA (KL2)
ResearchScholar · Awarded by National Institutes of Health · 2018 - 2024External Relationships
- ESCMID
- Resonantia Diagnostics, Inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.